With aim to strengthen its service portfolio, Atos has signed a share purchase agreement to acquire Anthelio Healthcare Solutions (Anthelio) for an enterprise value of US$275 million (8.5xEBIT post-synergies in 2017). This acquisition, fully financed by cash, uniquely positions Atos to reach a broader customer base in the U.S. healthcare market by strengthening the scale and scope of its services. The combined organization will support Atos customer’s need to better optimize financial performance, improve the patient care experience, engage patients through state-of-the-art applications and address the increasing demands of security, risk and compliance.
Anthelio generates about US$200 million of annual revenue growing at 8%. Thanks to strong revenue synergies, the Group expects the newly formed US healthcare practice to reach double digit organic growth in 2018.
“We are pleased to welcome the Anthelio team to Atos. With their strong and loyal customer base and our combined commitment to providing a world-class customer experience, our ambition with Anthelio is to reinforce our Healthcare footprint in the U.S. and to become the leader in digital healthcare solutions. I am pleased that Asif Ahmad, a recognized leader in the healthcare technology sector, currently CEO of Anthelio Healthcare Solutions, will lead our newly formed healthcare practice in the US”, said Michel-Alain Proch, Group Senior Executive Vice President and CEO North American Operations, Atos.
“This is an exciting development for Anthelio and its customers. Our vision has always been to drive high value for healthcare organizations by solving complex clinical and business problems. Combining Atos’ leadership in global digital services with Anthelio’s leadership in Healthcare Technology and Revenue Cycle Management is unprecedented. This acquisition addresses the many core clinical and financial processes that hospitals and physicians are faced with today,” said Asif Ahmad, CEO, Anthelio Healthcare Solutions.
Atos is acquiring Anthelio from Actis, a leading London-based growth markets investment firm, its majority shareholder since November 2010, as well as from McLaren Health Care Corporation, a leading fully integrated health network and the largest customer of Anthelio.
Philip A. Incarnati, President and CEO of McLaren Health Care Corporation said “As a long-time partner of Anthelio, I trust that Atos is the right choice to support McLaren’s future growth and digital transformation through our renewed 5-year contract”.
This acquisition aims to provide customers with expanded technology offerings that provide sustainable value in today’s evolving healthcare environment.The intended acquisition received the unanimous support of both the Atos and Anthelio Boards of Directors. The transaction is expected to close before the end of September 2016.